Pharming Group N.V.
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $75,062 | $74,030 | $55,455 | $81,866 |
Gross Profit | 68,224 | 66,038 | 47,089 | 74,708 |
EBITDA | 7,255 | -4,284 | -9,629 | 8,171 |
EBIT | 4,512 | -3,991 | -15,550 | 604 |
Net Income | -1,034 | -1,198 | -12,418 | -2,722 |
Net Change In Cash | 75,062 | 74,030 | 55,455 | 81,866 |
Free Cash Flow | 9,376 | -13,386 | -9,762 | 11,851 |
Cash | 60,662 | 47,142 | 51,892 | 61,741 |
Basic Shares | 646,250 | 847,942 | 838,841 | 671,073 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $245,316 | $205,622 | $189,853 | $228,394 |
Gross Profit | 220,104 | 188,060 | 169,670 | 203,056 |
EBITDA | 9,877 | 33,533 | 48,779 | 92,114 |
EBIT | -6,048 | 20,345 | 29,169 | 83,800 |
Net Income | -10,548 | 13,674 | 15,996 | 37,746 |
Net Change In Cash | 245,316 | 205,622 | 189,853 | 228,394 |
Free Cash Flow | -18,766 | 20,920 | 20,168 | 74,508 |
Cash | 61,741 | 207,342 | 191,724 | 205,485 |
Basic Shares | 657,020 | 883,926 | 876,439 | 853,421 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.01 |
2024-06-30 | -$0.01 |
2024-03-31 | -$0.18 |
2023-12-31 | -$0.04 |
